Roche’s MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion

Roche’s MS blockbuster Ocrevus, facing new Novartis competition, scores FDA nod for more-convenient infusion
aliu
Tue, 12/15/2020 – 10:11